ReGenesys

ReGenesys

ReGenesys

ReGenesys BVBA is a biotechnology company in Leuven, that is focused on the research and development of the multipotent adult progenitor cell (MAPC®) stem cell therapy technology, which is the basis for the MultiStem platform, and performs various preclinical studies and core research to further advance the technology.

 

ReGenesys has extensive experience in areas such as cell expansion, cell characterization and potency assays, as well as scientific and process development knowledge that supports Athersys’ MultiStem clinical programs.

 

ReGenesys has filed multiple patent applications related to its discoveries and is developing potential new regenerative medicine opportunities, such as animal health care.

 

ReGenesys collaborates with leading academic institutions and other biotechnology companies to further advance its programs.

Register now

Flanders.bio Strategic Partners